News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Insights
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Insights
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
296,031 Results
Type
Article (21810)
Company Profile (57)
Press Release (274161)
Multimedia
Podcasts (56)
Webinars (9)
Section
Business (82918)
Career Advice (389)
Deals (12313)
Drug Delivery (83)
Drug Development (27168)
Employer Resources (62)
FDA (8466)
Job Trends (7888)
News (126801)
Policy (17276)
Tag
2025 Best Places to Work (12)
2026 Best Places to Work (15)
2027 BioCapital Standard (3)
2027 BioMidwest Standard (1)
2027 Biotech Bay Standard (2)
2027 Pharm Country Standard (3)
40 Under 40 (1)
Academia (1895)
Academic (2)
Accelerated approval (40)
ADA (30)
Adcomms (18)
Allergies (98)
Alliances (21784)
ALS (101)
Alzheimer's disease (996)
Antibody-drug conjugate (ADC) (187)
Approvals (8992)
Artificial intelligence (460)
ASCO (94)
Autoimmune disease (153)
Automation (33)
Bankruptcy (110)
Belgium (14)
Best Places to Work (7198)
BIO (28)
Biologics (43)
BIOSECURE Act (4)
Biosimilars (150)
BioSpace Insights (61)
Biotechnology (27)
Bispecific (23)
Bladder cancer (105)
Brain cancer (38)
Breast cancer (382)
Cancer (2797)
Cardiovascular disease (339)
Career advice (375)
Career pathing (17)
CAR-T (95)
CDC (73)
CDMO (55)
Celiac Disease (3)
Cell-line development (1)
Cell therapy (321)
Cervical cancer (48)
Clinical research (24827)
Collaboration (1233)
Commercialization (38)
Company closure (2)
Compensation (172)
Complete response letters (31)
COVID-19 (2078)
CRISPR (60)
CRO (4)
C-suite (627)
Cystic fibrosis (65)
Data (4687)
Decentralized trials (3)
Denatured (14)
Depression (155)
Dermatology (123)
Diabetes (427)
Diagnostics (4356)
Digital health (79)
Diversity (7)
Diversity, equity & inclusion (22)
Drug discovery (165)
Drug pricing (151)
Drug shortages (13)
Duchenne muscular dystrophy (133)
Earnings (25391)
Editorial (45)
Employer branding (8)
Employer resources (59)
ESMO (128)
Events (42941)
Executive appointments (597)
Eye disease (8)
FDA (10891)
Fibrodysplasia Ossificans Progressiva (10)
Friedreich's ataxia (16)
Frontotemporal dementia (17)
Funding (1117)
Gene editing (103)
Generative AI (34)
Gene therapy (245)
GLP-1 (567)
Government (4221)
Grass and pollen (5)
Guidances (226)
Healthcare (11992)
Hematology (85)
HIV (92)
Huntington's disease (16)
Idiopathic pulmonary fibrosis (2)
IgA nephropathy (61)
Immunology and inflammation (61)
Immuno-oncology (47)
Indications (143)
Infectious disease (2401)
Inflammatory bowel disease (118)
Inflation Reduction Act (10)
Influenza (126)
Intellectual property (113)
Interviews (38)
IPO (5283)
IRA (31)
Job creations (981)
Job search strategy (321)
JPM (14)
Kidney cancer (9)
Kidney disease (88)
Labor market (43)
Layoffs (159)
Leadership (15)
Legal (3107)
Licensing (67)
Liver cancer (41)
Longevity (40)
Lung cancer (388)
Lung diease (13)
Lymphoma (206)
Machine learning (21)
Management (23)
Manufacturing (504)
Marketing (23)
MASH (109)
Medical affairs (3)
Medical device (6445)
Medtech (6594)
Melanoma (59)
Mergers & acquisitions (7665)
Metabolic disorders (980)
Middle East (1)
mRNA (135)
Multiple sclerosis (78)
Multispecific (1)
NASH (8)
Netherlands (14)
Neurodegenerative disease (224)
Neuropsychiatric disorders (64)
Neuroscience (1909)
Neurotech (1)
NextGen: Class of 2026 (3886)
Non-profit (3649)
Now hiring (15)
Obesity (432)
Opinion (138)
Ovarian cancer (79)
Pain (142)
Pancreatic cancer (140)
Parkinson's disease (177)
Partnered (17)
Patents (237)
Patient advocacy (4)
Patient recruitment (368)
Patient selection (41)
Peanut (32)
People (25286)
Peptides (21)
Pharmaceutical (20)
Pharmacy benefit managers (36)
Phase 1 (6102)
Phase 2 (9904)
Phase 3 (10146)
Pipeline (6382)
Policy (259)
Postmarket research (1321)
Preclinical (2432)
Press Release (20)
Prostate cancer (186)
Psychedelics (60)
Radioligand (1)
Radiopharmaceuticals (122)
Rare diseases (603)
Real estate (2076)
Recruiting (22)
Regenerative medicine (8)
Regulatory (13624)
Reports (30)
Research institute (1767)
Resumes & cover letters (27)
Rett syndrome (5)
RNA editing (7)
RSV (67)
Saudi Arabia (1)
Schizophrenia (120)
Series A (163)
Series B (117)
Service/supplier (3)
Sickle cell disease (83)
Special edition (13)
Spinal muscular atrophy (76)
Sponsored (21)
Startups (1459)
Stem cells (4)
Stomach cancer (2)
Substance use disorders (19)
Supply chain (71)
Switzerland (9)
Tariffs (42)
Tax incentives (1)
The Weekly (41)
Vaccines (942)
Venture capital (56)
Weight loss (280)
Wet AMD (3)
Women's health (173)
Worklife (8)
Date
Today (46)
Last 7 days (278)
Last 30 days (1431)
Last 365 days (12550)
2026 (11608)
2025 (12206)
2024 (14536)
2023 (16240)
2022 (22346)
2021 (25691)
2020 (27645)
2019 (25248)
2018 (19034)
2017 (12684)
2016 (13342)
2015 (14510)
2014 (10761)
2013 (8283)
2012 (8714)
2011 (9212)
2010 (7956)
Location
Africa (456)
Alabama (27)
Alaska (5)
Arizona (224)
Arkansas (12)
Asia (15517)
Australia (3009)
California (5545)
Canada (2490)
China (638)
Colorado (302)
Connecticut (366)
Delaware (177)
Europe (34910)
Florida (950)
Georgia (262)
Hawaii (3)
Idaho (33)
Illinois (758)
India (89)
Indiana (531)
Iowa (20)
Japan (423)
Kansas (83)
Kentucky (43)
Louisiana (51)
Maine (89)
Maryland (948)
Massachusetts (3887)
Michigan (184)
Minnesota (339)
Mississippi (3)
Missouri (112)
Montana (12)
Nebraska (18)
Nevada (109)
New Hampshire (53)
New Jersey (2182)
New Mexico (12)
New York (2026)
North Carolina (969)
North Dakota (5)
Northern California (2900)
Ohio (220)
Oklahoma (15)
Oregon (22)
Pennsylvania (1355)
Puerto Rico (11)
Rhode Island (25)
South America (519)
South Carolina (28)
South Dakota (2)
Southern California (2197)
Tennessee (144)
Texas (1053)
United States (23447)
Utah (324)
Virginia (167)
Washington D.C. (44)
Washington State (610)
West Virginia (3)
Wisconsin (83)
Wyoming (3)
296,031 Results for "guardant health".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Guardant Health Launches Guardant Reveal® Ultra to Deliver Leading Sensitivity in MRD Testing
November 19, 2026
·
4 min read
Press Releases
Guardant Health to Participate in Upcoming Investor Conferences - November 9, 2026
November 10, 2026
·
1 min read
Press Releases
Guardant Health Highlights Broad Liquid Biopsy Research Portfolio at ESMO Congress 2026
October 20, 2026
·
11 min read
Press Releases
Guardant Health COSMOS Study Published in Cancer Research Communications Validates Utility of Guardant Reveal™ Liquid Biopsy Test for Predicting Recurrence in Melanoma
October 5, 2026
·
6 min read
Press Releases
Guardant Health Announces Approval in Europe of Guardant360® CDx as Companion Diagnostic for AstraZeneca’s ETCAMAH™ (camizestrant) in Advanced ER-positive Breast Cancer
October 8, 2026
·
4 min read
Press Releases
Guardant Health and Collaborators to Present New Data Across the Cancer Care Continuum at ESMO 2025
October 25, 2026
·
6 min read
Press Releases
Guardant Health’s Shield Blood Test Covered by Carelon Health Services for Colorectal Cancer Screening
September 1, 2026
·
6 min read
Press Releases
Guardant Health Applauds New Law Ensuring Access to Colorectal Cancer Screening Innovations with No Cost-Sharing for Pennsylvanians
October 29, 2026
·
5 min read
Press Releases
PRECISION Study Published in ESMO Open Highlights Utility of Guardant360® Liquid and Guardant Reveal® to Assess Recurrence Risk After Surgery for Colorectal Cancer Metastases
November 10, 2026
·
6 min read
Press Releases
Guardant Health to Participate in Upcoming Investor Conferences - July 29, 2026
July 29, 2026
·
1 min read
1 of 29,604
Next